Typhoid Fever among Children, Ghana by Marks, Florian et al.
LETTERS
Typhoid Fever 
among Children, 
Ghana
To the Editor: Typhoid fever 
(TF) remains a problem of concern in 
many low-income countries. Salmo-
nella enterica serovar Typhi causes 
≈22,000,000 symptomatic infections 
and 220,000 fatalities worldwide an-
nually (1). However, the effect and 
incidence of TF in many parts of sub-
Saharan Africa are largely unknown 
because diagnostic laboratories are 
lacking and fatal TF is frequently at-
tributed to malaria (2,3). In Ghana, 
TF ranks among the leading 20 causes 
of outpatient illness, accounting for 
0.92% of hospital admissions (4).
We conducted our study at the 
rural Agogo Presbyterian Hospital 
in the Ashanti Region of Ghana. The 
percentage of residents of 99 villages 
and household clusters of buildings 
(population size 18–13,559 persons, 
median 277 persons) with access to 
the study hospital was assessed in a 
healthcare utilization survey. A pro-
portional-to-size number of children 
were randomly selected in each vil-
lage, and a standardized interview 
was conducted. TF incidences were 
calculated for September 2007–No-
vember 2008 (Table). A bacteriology 
laboratory with BACTEC 9050 auto-
mated blood culture system (Becton 
Dickinson, Sparks, MD, USA) was 
established in the study hospital and 
run to assess the number of admis-
sions with TF, the incidence of TF in 
the adjoining community and S. en-
terica ser. Typhi resistance to a panel 
of antimicrobial drugs.
The study included 1,456 children 
<15 years of age who were admitted to 
the pediatric ward of Agogo Presbyte-
rian Hospital over the 23-month study 
period. Overall, 52.1% were male; 
mean age of children was 32.2 months 
(SD ± 36.0 months; median 19 months, 
range 0–174 months). Blood was cul-
tured by using a BACTEC 9050 blood 
culture system (Becton Dickinson), and 
positive samples were examined by 
standard methods. Antimicrobial drug 
susceptibility testing was performed on 
all serovar Typhi isolates by using the 
Kirby-Bauer disk-diffusion method for 
ampicillin, chloramphenicol, tetracy-
cline, trimethoprim/sulfamethoxazole,
amoxicillin/clavulanicacid, gentamicin,
ciproﬂ  oxacin, and ceftriaxone.
Children <2 years of age had the 
highest proportion of positive blood 
cultures (164/1,456, 21.3%; online 
Appendix Figure, www.cdc.gov/EID/
content/16/11/1796-appF.htm). Of 
298 blood cultures yielding positive 
growth for bacterial pathogens or for 
Candida spp., 37 (12.4%) isolates 
(2.5% of the 1,456 hospitalized chil-
dren) were positive for S. enterica 
ser. Typhi. The frequency of TF was 
low among children <2 years of age 
(7/1,018, 0.7%), increased among 
those 2 to <11 years of age (29/417, 
7.0%), and decreased among children 
≥11 years of age (1/22, 4.6%) (online 
Appendix Figure). One (2.7%) child 
with TF died. Malaria parasites were 
detected in 2 children with S. enter-
ica ser. Typhi. Pathogens other than 
S. enterica ser. Typhi were identiﬁ  ed 
among 21.3% and 11.8% of children 
0 to <2 years and 5 to <8 years of 
age, respectively. These pathogens 
included nontyphoidal salmonellae, 
Staphylococcus aureus, and Strep-
tococcus pneumoniae.  S. enterica 
ser. Typhi isolates were resistant to 
chloramphenicol (73%), trimethop-
rim/sulfamethoxazole (71%), am-
picillin/amoxicillin (70%), tetracy-
cline (64%), gentamicin (46%), and 
amoxicillin/clavulanic acid (24%) 
but susceptible to ciproﬂ  oxacin and 
ceftriaxone.
TF incidence in children <5 years 
of age was ≈190 cases/100,000 popu-
lation and highest in children 2–5 
years of age (290/100,000 per year) 
and 5–8 years of age (200/100,000 
per year) (Table). In children older 
than 8, incidence decreased continu-
ously, and the number of cases was 
too low to enable precise age-strati-
ﬁ   ed incidence calculations. The in-
cidences in the study area point to a 
higher impact of TF than expected (4) 
and may reﬂ  ect an underestimation of 
TF in other West African regions as 
well. Our high incidence ﬁ  gure may 
still underestimate the incidence be-
cause of a low sensitivity of standard 
microbiologic methods (up to 50%), 
which are prone to underdiagnose 
moderate bacteremia in Salmonella 
infections (5,6).
Compared with Asia, only lim-
ited data are available from Africa on 
S. enterica ser. Typhi drug resistance. 
A study from Nigeria showed that, 
among serovar Typhi strains isolated 
from hospitalized patients in Lagos 
during 1997–2004, resistance rates 
reached 87% for ampicillin and were 
0.7% for ciproﬂ  oxacin, compared with 
70% and 0%, respectively, in the pres-
ent study. Resistance to trimethoprim/
sulfamethoxazole was 59% in Nige-
ria, compared with 71% in Ghana. In 
Togo, proportions of serovar Typhi 
strains resistant to chloramphenicol 
and trimethoprim/sulfamethoxazole 
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Table. Estimates of Salmonella enterica serovar Typhi incidence in children, Ghana, 
September 2007–November 2008 
Age group, y 
No. S. enterica
ser. Typhi isolates* 
Coverage
population†
Incidence‡
(95% confidence interval) 
0–15  16 14,933  120 (70 to 170) 
  <2  1 2,133  50 (–30 to 140) 
  2–<5  8 3,200  290 (120 to 450) 
  5–<8  5 2,880  200 (50 to 340) 
  8–<11  1 2,880  40 (–30 to 110) 
  11–<15  1 3,840  30 (–20 to 80) 
*Observation period 15 mo (period of complete and uninterrupted assessment of blood culture data).
†No. residents of each community with access to Agogo Presbyterian Hospital. 
‡Per 100,000 persons per year. LETTERS
were 33% and 46%, respectively, be-
fore 2002 and 73% and 79% in 2003–
2004 (7) and thus similar to those in 
our study.
In addition, resistances to cipro-
ﬂ  oxacin and ceftriaxone were <10%. 
Multidrug resistance (resistance to 
ampicillin, trimethoprim/sulfame-
thoxazole, and chloramphenicol) was 
observed in 63% of children in our 
study, compared with 7% in India, 
22% in Vietnam, and 65% in Pakistan 
(8–10).
More effort is needed in Africa 
to enable reliable and standardized 
laboratory diagnoses of Salmonella 
infections and to sustain TF surveil-
lance and drug sensitivity surveys. 
Moreover, introduction of a vaccina-
tion program should be discussed af-
ter more data are obtained from other 
areas in Ghana and West Africa. Such 
data currently are collected in an ex-
tensive standardized surveillance pro-
gram across the continent performed 
by our group and others. In parallel, 
trials should be conducted to assess 
the effectiveness and cost-effective-
ness of currently available and newly 
developed TF vaccines.
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Shigella spp. 
Antimicrobial Drug 
Resistance, Papua 
New Guinea, 2000–
2009
To the Editor: Approximately 
half the Shigella spp. infections in 
developing countries are caused by 
endemic shigellae (1), which in these 
countries are responsible for ≈10% of 
all episodes of diarrhea among chil-
dren <5 years of age and up to 75% of 
deaths from diarrhea (2). Deaths from 
epidemic Shigella spp. in the commu-
nity are estimated to outnumber deaths 
within the healthcare setting. In Papua 
New Guinea, diarrhea is a major cause 
of hospital admission and death (3); 
Shigella spp. are among the most com-
mon causes of enteric bacterial infec-
tion (4,5), and S. ﬂ  exneri is the most 
common serotype (3,6). Outbreaks of 
bloody diarrhea are frequently report-
ed; however, diagnosis in remote set-
tings is challenging, partly because the 
storage requirements for the organism 
are difﬁ  cult to meet.
Multidrug resistance of shigellae 
is not new (1); many countries have 
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